1.SALL4 and its clinical application value in non-germ cell tumors
Yuanyuan CHEN ; Yuanyuan YE ; Feng XU ; Zhizhen LI ; Yingbin LIU ; Baosan HAN
Journal of International Oncology 2016;43(2):155-158
Sal-like 4 (SALL4) plays an important role in promoting the cellular proliferation and maintaining the pluripotency of embryonic stem cells and tumor cells.In fully differentiated cells,the expression of SALL4 is silenced or down-regulated.However,the expression of SALL4 is found to be restored or up-regulated in a variety of non-germ cell tumors.Besides,the expression of SALL4 is often associated with disease progression,treatment effect and prognosis.Therefore,examining the expression level of SALL4 will be of great importance in the diagnosis of disease and monitoring the disease progression for non-germ cell tumors.
2.Diagnostic value of MR imaging in congenital cystic lung disease:comparative study with ultrasound
Zhiqiu YE ; Zhizhen DENG ; Wenjun CHEN ; Qingshan HONG ; Xiaoming HE ; Gang YU
Journal of Practical Radiology 2015;(7):1171-1174
Objective To investigate the value of MRI in diagnosis of congenital cystic lung disease.Methods The MRI was per-formed in 105 fetuses with congenital cystic lung disease.Subjects were classified into two groups including group A (the gestational age ranged from 12-20 w)and group B (the gestational age>20 w).The MRI and ultrasonography characteristics,as well as path-ologic diagnosis were compared.Results Among 105 cases,there were 80 cases of congenital cystic adenomatoid malformation (CCAM)(including 23 cases of typeⅠ,38 cases of typeⅡ and 1 9 cases of typeⅢ),18 cases of bronchopulmonary sequestration (BPS),5 cases of congenital lobar emphysema,1 case of bronchogenic cyst,and 1 case was BPS with CCAM.In group A,MRI can diagnose the majority of the anomalies (41/45),ultrasonography can diagnose anomalies of 39 cases.There was no significant differ-ence of diagnostic accuracy between the two methods (P >0.05).In group B,compared with ultrasonography,MRI could diagnose more cases accurately (58 vs 52),with statistical significance (P <0.05).Conclusion MRI is a reliable method in diagnosing con-genital cystic lung disease;MRI can provide more useful information for the cases in the gestational age >20 w compared with ultra-sonography.
3.Analysis of efficacy and adverse effects of entecavir in the treatment of decompensate cirrhosis patients with chronic hepatitis B
Chinese Journal of Primary Medicine and Pharmacy 2017;24(24):3701-3704
Objective To explore the efficacy and adverse effects of entecavir in the treatment of decompensate cirrhosis patients with chronic hepatitis B.Methods 80 decompensate cirrhosis patients with chronic hepatitis B were selected as the research subjects.The patients were randomly divided into two groups according to the digital table.The control group was given conventional treatment,and the observation group was treated with entecavir on the basis of conventional treatment.The hepatitis B virus deoxyribonucleic acid (HBV-DNA) changes,the changes of liver function,the incidence ofadverse reactions were compared between the two groups.Results Before treatment,the HBV-DNA,ALT and AST levels had no significant differences between the two groups (all P > 0.05).After treatment for 4,12,24 and 48 weeks,the levels of HBV-DNA,ALT and AST of the observation group and the control group were significantly lower than those before treatment (all P < 0.05),which of the observation group were significantly lower than those of the control group (all P < 0.05).The incidence rate of adverse reaction of the observation group was 17.5%,which was significantly lower than 40.0% of the control group,the difference was statistically significant(x2 =8.345,P <0.05).Conclusion The entecavir can effectively reduce the level of HBV-DNA,improve liver function and without significant adverse effects in treating decompensate cirrhosis patients with chronic hepatitis B.
4.Application of prophylactic bilateral internal iliac arteries balloon occlusion in treating pernicious placenta previa complicated with placenta implantation
Xiaoming HE ; Zhizhen DENG ; Yubin NG HUA ; Qingshan HONG ; Shiwei MEI ; Zhiqiu YE
Journal of Practical Radiology 2017;33(12):1935-1938
Objective To explore prophylactic bilateral internal iliac arteries balloon occlusion in treating pernicious placenta previa complicated with placenta implantation before cesarean section.Methods Data of 32 patients with pernicious placenta previa complicated with placenta implantation underwent prophylactic bilateral internal iliac arteries balloon occlusion(Balloon Group)were analyzed retrospectively.40 patients with pernicious placenta previa complicated with placenta implantation without treatment of prophylactic bilateral internal iliac arteries balloon occlusion(Control Group)were selected.The mean blood loss and infusion amount during the operation,operative time,newborn Apgar score were compared between the two groups.Results The mean blood loss and infusion amount during the operation,operative time,newborn Apgar score of balloon group was superior to the control group and the difference was significant.All mothers and infants were healthy detected by clinical checking on 3-6 months after birth.Conclusion Prophylactic bilateral internal iliac arteries balloon occlusion is a safe and effective treatment before cesarean section used in pernicious placenta previa complicated with placenta implantation,and worthy of further promotion.
5.Effects of Feitai Capsule on quality of life in patients with advanced non-small-cell lung cancer: a randomized controlled trial.
Zhizhen LIU ; Zongyang YU ; Xuenong OUYANG ; Xihu DAI ; Xi CHEN ; Zhongquan ZHAO ; Wenwu WANG ; Jie LI ; Hua TU ; Lei YE ; Yan YAN
Journal of Integrative Medicine 2009;7(7):611-5
Recently the maintenance therapy of non-small-cell lung cancer (NSCLC) patients who completed required treatment cycles has caused widespread interests in the medical field. Traditional Chinese medicine may be a useful complement in maintenance treatment of mid-to-late stage NSCLC.